Apimeds Pharmaceuticals US, Inc. - APUS
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 8
Latest filed: Mar 26, 2026
| Form | Count |
|---|---|
| 8-K | 4 |
| SCHEDULE 13D/A | 2 |
| 8-K/A | 1 |
| SCHEDULE 13G | 1 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| Mar 26, 2026 | 8-K | Mar 20, 2026 | 0001213900-26-034786 | View |
| Mar 25, 2026 | 8-K | Mar 20, 2026 | 0001213900-26-033832 | View |
| Mar 20, 2026 | SCHEDULE 13D/A | — | 0001213900-26-032480 | View |
| Mar 16, 2026 | 8-K | Mar 16, 2026 | 0001213900-26-028332 | View |
| Feb 17, 2026 | 8-K/A | Dec 01, 2025 | 0001213900-26-017323 | View |
| Feb 11, 2026 | SCHEDULE 13G | — | 0001493152-26-006136 | View |
| Jan 26, 2026 | SCHEDULE 13D/A | — | 0001213900-26-007438 | View |
| Jan 02, 2026 | 8-K | Dec 30, 2025 | 0001213900-26-000464 | View |